quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:51:08·65d
ANALYSTRating
Innoviva Inc. logo

BTIG Research initiated coverage on Innoviva with a new price target

INVA· Innoviva Inc.
Health Care
Original source

Companies

  • INVA
    Innoviva Inc.
    Health Care

Recent analyst ratings

  • Feb 17UpdateBTIG Research$35.00
  • Sep 30UpdateGoldman$17.00
  • Aug 11UpdateOppenheimer$45.00
  • Jul 14UpdateH.C. Wainwright$40.00
  • Jul 11UpdateCantor Fitzgerald$26.00
  • Mar 7UpdateScotiabank$55.00

Related

  • SEC27d
    Amendment: SEC Form 10-K/A filed by Innoviva Inc.
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Innoviva Inc.
  • SEC30d
    SEC Form DEF 14A filed by Innoviva Inc.
  • SEC57d
    Innoviva Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
  • SEC57d
    SEC Form 10-K filed by Innoviva Inc.
  • INSIDER58d
    Chief Financial Officer Basso Stephen covered exercise/tax liability with 1,244 shares, decreasing direct ownership by 2% to 50,013 units (SEC Form 4)
  • INSIDER58d
    Chief Executive Officer Raifeld Pavel covered exercise/tax liability with 2,986 shares, decreasing direct ownership by 2% to 159,290 units (SEC Form 4)
  • INSIDER58d
    Chief Accounting Officer Zhen Marianne covered exercise/tax liability with 2,460 shares, decreasing direct ownership by 5% to 45,877 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022